- Home
- IMMX vs ALTS Comparison
IMMX vs ALTS Comparison
Compare IMMX & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- ALTS
- Stock Information
- Founded
- IMMX 2014
- ALTS 1976
- Country
- IMMX United States
- ALTS United States
- Employees
- IMMX N/A
- ALTS N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- ALTS
- Sector
- IMMX Health Care
- ALTS
- Exchange
- IMMX Nasdaq
- ALTS NYSE
- Market Cap
- IMMX 61.1M
- ALTS 54.0M
- IPO Year
- IMMX 2021
- ALTS N/A
- Fundamental
- Price
- IMMX $2.10
- ALTS $4.33
- Analyst Decision
- IMMX Strong Buy
- ALTS
- Analyst Count
- IMMX 1
- ALTS 0
- Target Price
- IMMX $7.00
- ALTS N/A
- AVG Volume (30 Days)
- IMMX 247.3K
- ALTS 233.4K
- Earning Date
- IMMX 11-12-2024
- ALTS 01-03-2025
- Dividend Yield
- IMMX N/A
- ALTS N/A
- EPS Growth
- IMMX N/A
- ALTS N/A
- EPS
- IMMX N/A
- ALTS N/A
- Revenue
- IMMX N/A
- ALTS $7,110,000.00
- Revenue This Year
- IMMX N/A
- ALTS N/A
- Revenue Next Year
- IMMX $200.00
- ALTS N/A
- P/E Ratio
- IMMX N/A
- ALTS N/A
- Revenue Growth
- IMMX N/A
- ALTS N/A
- 52 Week Low
- IMMX $1.26
- ALTS $0.50
- 52 Week High
- IMMX $7.10
- ALTS $5.26
- Technical
- Relative Strength Index (RSI)
- IMMX 50.86
- ALTS 74.42
- Support Level
- IMMX $2.04
- ALTS $3.33
- Resistance Level
- IMMX $2.44
- ALTS $4.50
- Average True Range (ATR)
- IMMX 0.31
- ALTS 0.37
- MACD
- IMMX -0.03
- ALTS 0.09
- Stochastic Oscillator
- IMMX 26.51
- ALTS 91.37
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.